Cotherix logo — Pioneering new frontiers in the treatment of cardiopulmonary...

Cotherix

Pioneering new frontiers in the treatment of cardiopulmonary and chronic diseases with innovative therapeutic solutions.

Founded 2000 Series C Total: $55.00M Biotechnology, Finance +2

General Information

Company Name Cotherix
Founded Year 2000
Industries Biotechnology, Finance, Health and Wellness +1
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with Cotherix. To contact Cotherix, visit cotherix.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Cotherix compare?

A PDF of Cotherix and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Cotherix soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Cotherix

Cotherix is a biopharmaceutical company founded in 2000. The company is focused on pioneering new frontiers in the treatment of cardiopulmonary and chronic diseases with innovative therapeutic solutions. Cotherix is dedicated to licensing, developing, and commercializing therapeutic solutions aimed at treating cardiopulmonary and other chronic illnesses. Their main product candidate, Ventavis, is an inhalable formulation of iloprost designed to address specific medical needs. In October 14, 2003, Cotherix secured a $55.00M Series C investment from a group of investors including MPM Capital, Sofinnova Partners, Alta Partners, Frazier Healthcare Partners, Sofinnova Investments, Vivo Capital, Thomas Weisel Venture Partners, and Spray Venture Partners. The company operates within the industries of biotechnology, finance, health and wellness, and pharmaceuticals. Cotherix's focus on innovative therapeutic solutions for chronic illnesses, combined with its recent significant investment, positions the company well for potential growth and impact in the biopharmaceutical industry.

Business keywords: biopharmaceutical, therapeutic solutions, cardiopulmonary diseases, chronic illnesses, Ventavis, iloprost, licensing, development, commercialization

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series C $55.00M 8
MPM Capital, Sofinnova Partners +6
14 Oct 2003
Venture Round Undisclosed 1
Sofinnova Investments
01 Jan 2001

Cotherix Alternatives & Competitors

View All Alternatives
Cotherix vs

Pioneering the future of medicine with innovative and long-lasting therapeutic proteins to combat ch...

Non Equity Assistance
Biotechnology, Health and Wellness
Cotherix vs
Verona Pharma
Verona Pharma United Kingdom

Developing life enhancing treatments for chronic respiratory diseases

Post-IPO Debt
195 employees
Biotechnology, Health and Wellness
Cotherix vs
Lumos Pharma
Lumos Pharma United States

Transforming Lives with Rare Focus

Series B
47 employees
Biopharma, Biotechnology

FAQ About Cotherix

Pioneering new frontiers in the treatment of cardiopulmonary and chronic diseases with innovative therapeutic solutions.
Cotherix was founded in 2000.
Cotherix operates in Biotechnology, Finance, Health and Wellness and Pharmaceutical. Its work centres on biopharmaceutical, therapeutic solutions, cardiopulmonary diseases and chronic illnesses.
Cotherix has completed 2 funding rounds, raising a total of $55.00M. The latest funding stage is Series C.
Top alternatives and competitors to Cotherix include DNX Biopharmaceuticals, Verona Pharma, Lumos Pharma, Applied Immune Technologies, Quoin Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cotherix and DNX Biopharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Cotherix, https://bouncewatch.com/company/cotherix, updated 26 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes